Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uma Sinha

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 17, 2002
Design and synthesis of factor Xa inhibitors and their prodrugsYonghong Song, Lane Clizbe, Chhaya Bhakta, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2002
Substituted acrylamides as factor Xa inhibitors: improving bioavailability by P1 modificationYonghong Song, Lane Clizbe, Chhaya Bhakta, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Inhibitory effect of carboxylic acid group on hERG bindingBing-Yan Zhu, Zhaozhong J Jia, Penglie Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Design, synthesis, and structure-activity relationships of unsubstituted piperazinone-based transition state factor Xa inhibitorsWenrong Huang, Mary Ann Naughton, Hua Yang, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Design, synthesis and biological activity of novel non-amidine factor Xa inhibitors. Part 1: P(1) structure-activity relationships of the substituted 1-(2-Naphthyl)-1H-pyrazole-5-carboxylamidesZhaozhong J Jia, Yanhong Wu, Wenrong Huang, et al.
Nature Medicine|March 5, 2013
A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor XaGenmin Lu, Francis R DeGuzman, Stanley J Hollenbach, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Design, synthesis, and SAR of monobenzamidines and aminoisoquinolines as factor Xa inhibitorsPenglie Zhang, Jingmei F Zuckett, John Woolfrey, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2011
Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritisGreg Coffey, Francis DeGuzman, Mayuko Inagaki, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors with improved functional activityPenglie Zhang, Liang Bao, Jingmei F Zuckett, et al.
Blood Advances|January 4, 2018
Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfaDeborah Siegal, Genmin Lu, Janet M Leeds, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|December 17, 2002
Design and synthesis of factor Xa inhibitors and their prodrugsYonghong Song, Lane Clizbe, Chhaya Bhakta, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2002
Substituted acrylamides as factor Xa inhibitors: improving bioavailability by P1 modificationYonghong Song, Lane Clizbe, Chhaya Bhakta, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Inhibitory effect of carboxylic acid group on hERG bindingBing-Yan Zhu, Zhaozhong J Jia, Penglie Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Design, synthesis, and structure-activity relationships of unsubstituted piperazinone-based transition state factor Xa inhibitorsWenrong Huang, Mary Ann Naughton, Hua Yang, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Design, synthesis and biological activity of novel non-amidine factor Xa inhibitors. Part 1: P(1) structure-activity relationships of the substituted 1-(2-Naphthyl)-1H-pyrazole-5-carboxylamidesZhaozhong J Jia, Yanhong Wu, Wenrong Huang, et al.
Nature Medicine|March 5, 2013
A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor XaGenmin Lu, Francis R DeGuzman, Stanley J Hollenbach, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Design, synthesis, and SAR of monobenzamidines and aminoisoquinolines as factor Xa inhibitorsPenglie Zhang, Jingmei F Zuckett, John Woolfrey, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2011
Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritisGreg Coffey, Francis DeGuzman, Mayuko Inagaki, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors with improved functional activityPenglie Zhang, Liang Bao, Jingmei F Zuckett, et al.
Blood Advances|January 4, 2018
Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfaDeborah Siegal, Genmin Lu, Janet M Leeds, et al.
Pageof 8